Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Engine MHP

- PMLiVE

Inizio announced as headline sponsor for 2026 Communiqué Awards

The PMGroup Awards celebrate excellence in health communications

- PMLiVE

Communiqué 2025: celebrating excellence in healthcare communications

This year’s Awards, held at the Grosvenor House Hotel in London on 3 July, included 30 categories

- PMLiVE

Communiqué Awards

Announcement about the results of the Media Relations category

- PMLiVE

The Communiqué Awards announces PAPYRUS as 2024 charity partner

PAPYRUS Prevention of Young Suicide aims to shatter the stigma that still surrounds suicide

- PMLiVE

Alzheimer’s Research UK awards Scottish universities £100,000 for dementia research

The neurological condition affects more than 944,000 people in the UK

- PMLiVE

Study suggests health and lifestyle factors could be linked to young-onset dementia

There are around 370,000 new cases of young-onset dementia globally every year

- PMLiVE

New £5m project launched to bring Alzheimer’s blood tests to the NHS

Blood tests for the condition could become available on the NHS within five years

- PMLiVE

Alzheimer’s Research UK survey highlights dementia knowledge gaps

The UK poll revealed that only 60% of adults know that dementia is a cause of death

- PMLiVE

Alzheimer’s Research UK awards Cardiff University researchers £387,000

The researchers will investigate how genes accelerate the development of Alzheimer’s disease

- PMLiVE

Alzheimer’s Research UK launches ‘Change The Ending’ campaign

A survey revealed that 22% of 2,162 people were unaware of the impact dementia has on people’s everyday lives

- PMLiVE

Alzheimer’s Research UK calls on party leaders to tackle dementia pressures

One in three people living with dementia in England never receive a formal diagnosis

- PMLiVE

Alzheimer’s Research UK awards £370,000 to University of Exeter researchers

The grants are part of a wider £3m funding announcement that aims to accelerate effective treatments for dementia

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links